BACKGROUND: Diagnosis-based case-mix measures are increasingly used for provider profiling, resource allocation, and capitation rate setting. Measures developed in one setting may not adequately capture the disease burden in other settings. OBJECTIVES: To examine the feasibility of adapting two such measures, Adjusted Clinical Groups (ACGs) and Diagnostic Cost Groups (DCGs), to the Department of Veterans Affairs (VA) population. RESEARCH DESIGN: A 60% random sample of veterans who used health care services during FY 1997 was obtained from VA inpatient and outpatient administrative databases. A split-sample technique was used to obtain a 40% sample (n = 1,046,803) for development and a 20% sample (n = 524,461) for validation. METHODS: Concurrent ACG and DCG risk adjustment models, using 1997 diagnoses and demographics to predict FY 1997 utilization (ambulatory provider encounters, and service days-the sum of a patient's inpatient and outpatient visit days), were fitted and cross-validated. RESULTS: Patients were classified into groupings that indicated a population with multiple psychiatric and medical diseases. Model R-squares explained between 6% and 32% of the variation in service utilization. Although reparameterized models did better in predicting utilization than models with external weights, none of the models was adequate in characterizing the entire population. For predicting service days, DCGs were superior to ACGs in most categories, whereas ACGs did better at discriminating among veterans who had the lowest utilization. CONCLUSIONS: Although "off-the-shelf" case-mix measures perform moderately well when applied to another setting, modifications may be required to accurately characterize a population's disease burden with respect to the resource needs of all patients.
BACKGROUND: Diagnosis-based case-mix measures are increasingly used for provider profiling, resource allocation, and capitation rate setting. Measures developed in one setting may not adequately capture the disease burden in other settings. OBJECTIVES: To examine the feasibility of adapting two such measures, Adjusted Clinical Groups (ACGs) and Diagnostic Cost Groups (DCGs), to the Department of Veterans Affairs (VA) population. RESEARCH DESIGN: A 60% random sample of veterans who used health care services during FY 1997 was obtained from VA inpatient and outpatient administrative databases. A split-sample technique was used to obtain a 40% sample (n = 1,046,803) for development and a 20% sample (n = 524,461) for validation. METHODS: Concurrent ACG and DCG risk adjustment models, using 1997 diagnoses and demographics to predict FY 1997 utilization (ambulatory provider encounters, and service days-the sum of a patient's inpatient and outpatient visit days), were fitted and cross-validated. RESULTS:Patients were classified into groupings that indicated a population with multiple psychiatric and medical diseases. Model R-squares explained between 6% and 32% of the variation in service utilization. Although reparameterized models did better in predicting utilization than models with external weights, none of the models was adequate in characterizing the entire population. For predicting service days, DCGs were superior to ACGs in most categories, whereas ACGs did better at discriminating among veterans who had the lowest utilization. CONCLUSIONS: Although "off-the-shelf" case-mix measures perform moderately well when applied to another setting, modifications may be required to accurately characterize a population's disease burden with respect to the resource needs of all patients.
Authors: Sara E Evans-Lacko; Susan Dosreis; Elizabeth A Kastelic; Cristiane S Paula; Donald M Steinwachs Journal: Prim Care Companion J Clin Psychiatry Date: 2010
Authors: Matthew L Maciejewski; Chuan-Fen Liu; Ann Derleth; Mary McDonell; Steve Anderson; Stephan D Fihn Journal: Health Serv Res Date: 2005-06 Impact factor: 3.402
Authors: Jefferson G Bohan; Richard Remington; Makoto Jones; Matthew Samore; Karl Madaras-Kelly Journal: Open Forum Infect Dis Date: 2016-12-10 Impact factor: 3.835
Authors: Bonnie K Lind; Mary M Gerkovich; Daniel C Cherkin; Richard A Deyo; Karen J Sherman; William E Lafferty Journal: J Altern Complement Med Date: 2012-10-04 Impact factor: 2.579
Authors: Amy K Rosen; Susan A Loveland; Jennifer J Anderson; Cheryl S Hankin; James N Breckenridge; Dan R Berlowitz Journal: Health Serv Res Date: 2002-08 Impact factor: 3.402
Authors: Chuan-Fen Liu; Anne E Sales; Nancy D Sharp; Paul Fishman; Kevin L Sloan; Jeff Todd-Stenberg; W Paul Nichol; Amy K Rosen; Susan Loveland Journal: Health Serv Res Date: 2003-10 Impact factor: 3.402
Authors: Theodore A Omachi; Steven E Gregorich; Mark D Eisner; Renee A Penaloza; Irina V Tolstykh; Edward H Yelin; Carlos Iribarren; R Adams Dudley; Paul D Blanc Journal: Med Care Date: 2013-08 Impact factor: 2.983